A groundbreaking portable diagnostic device is set to transform tuberculosis (TB) testing in Pakistan by offering a faster, more affordable, and accessible solution for early disease detection.

Researchers have developed a compact testing device capable of detecting tuberculosis from a simple tongue swab within 30 minutes. The test costs approximately $4, which is around Rs. 1,100, making it a cost-effective option for communities with limited healthcare resources.

The innovation is expected to play a significant role in improving TB screening, particularly in remote and underserved regions where access to hospitals, laboratories, and specialized medical facilities remains a challenge.

A major milestone for the technology came in March when the World Health Organization (WHO) officially recommended the test. The endorsement is particularly significant because it marks the first molecular tuberculosis test approved by the WHO for use in community settings without requiring full laboratory infrastructure.

Traditional TB testing methods often involve sputum samples, laboratory equipment, and longer waiting times for results. In contrast, the new device utilizes a non-invasive tongue swab, simplifying the testing process while reducing barriers that may discourage people from seeking diagnosis.

Healthcare experts believe that faster and more accessible testing can help identify infections earlier, allowing patients to begin treatment sooner and reducing the risk of disease transmission within communities.

Pakistan remains among the countries carrying a high tuberculosis burden, making advancements in diagnostic technologies especially important. Early detection is widely regarded as one of the most effective tools in controlling the spread of TB and improving patient outcomes.

The portability of the device also makes it suitable for field operations, mobile health units, community clinics, and public health campaigns. Medical workers can conduct tests on-site without relying on sophisticated laboratory setups, helping expand healthcare coverage to hard-to-reach populations.

Public health specialists view the development as a promising step toward strengthening tuberculosis control efforts globally. By combining affordability, speed, and ease of use, the device has the potential to improve access to life-saving diagnostic services for millions of people.

As countries continue to seek innovative solutions to combat infectious diseases, this portable TB testing device could become a valuable tool in enhancing healthcare accessibility and supporting early intervention strategies.